• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    0.20 Down 0.01(4.76%) Feb 5, 4:00PM EST
    Prev Close:0.21
    Open:0.21
    Bid:N/A
    Ask:0.22 x 1000
    1y Target Est:8.00
    Beta:0.774722
    Next Earnings Date:N/A
    Day's Range:0.20 - 0.22
    52wk Range:0.20 - 3.17
    Volume:466,687
    Avg Vol (3m):1,769,500
    Market Cap:27.56M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 4.76%27.56M
    INFIDown 4.35%281.60M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Dec-15) :-0.16
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback